Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Innovative Pharmaceutical Biotech ( (HK:0399) ) has issued an update.
Innovative Pharmaceutical Biotech Limited reported its audited annual results for the financial year ending March 31, 2025, revealing a significant financial downturn. The company experienced a substantial loss of HK$570.3 million, compared to a profit of HK$98.7 million the previous year, primarily due to an impairment loss on intangible assets and increased finance costs, impacting its market positioning and stakeholder interests.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited is a company incorporated in the Cayman Islands and continued in Bermuda, operating within the pharmaceutical and biotechnology industry. The company focuses on the development and commercialization of innovative pharmaceutical products and biotechnological solutions.
Average Trading Volume: 2,095,821
Technical Sentiment Signal: Hold
Current Market Cap: HK$378.4M
Learn more about 0399 stock on TipRanks’ Stock Analysis page.